Breakthrough study finds GLP-1s reduced risk of developing breast…

A new study suggests that taking GLP-1, a common weight loss medication, is also related with a decrease risk of developing breast cancer.

According to ABC News chief medical correspondent Dr. Tara Narula, “GLP[-1]s had a reduced risk of developing breast cancer by about 30%.”

In an interview with Good Morning America, Narual spoke about the hyperlink between GLP-1s and breast cancer and explained that after menopause, fats cells produce estrogen throughout the physique and larger ranges of estrogen may imply larger risk of breast cancer.

“When you think about what [GLP-1s] do — reduce weight, reduce inflammation and help with insulin sensitivity — it makes sense that that could potentially have an effect on the risk of breast cancer,” she said.

Elevated insulin can also trigger obesity, which could lead on to inreased risk of cancer, according to Narula.

Elizabeth McDonald, M.D., Ph.D. the study’s lead writer and a professor of radiology in the University of Pennsylvania Perelman School of Medicine, said in a assertion that the findings have been “observational” and don’t “definitively confirm an association between GLP-1 medications and reduced breast cancer incidence,” however the study “does add to the growing body of evidence suggesting that it’s worth investigating these weight-loss drugs as potential cancer prevention tools.”

Breast cancer is the second-most common cancer among ladies in the U.S. behind pores and skin cancer, according to the Centers for Disease Control and Prevention, accounting for 1 in 3 new feminine cancer diagnoses every yr.

The study provides to a physique of research being accomplished in this subject and Narula, too, cautioned this is “hypothesis-generating” not “practice-changing” research.

Breast cancer is also the second main trigger of cancer-related deaths among ladies, second only after lung cancer, according to the American Cancer Society, although death charges have been reducing over the last three many years.

Currently, the U.S. Preventive Services Task Force recommends ladies between ages 40 and 74 who are at average risk for breast cancer get a mammogram every two years.